Technology News

NeuroMetrix Receives Clearance For Pain Mgmnt Device

Tuesday, August 07, 2012 5:14:00 AM PDT | VentureDeal

   Waltham, Massachusetts  --  Diabetes neurology company NeuroMetrix (NASDAQ: NURO) has received FDA 510(k) marketing clearance for its new pain management device.

Called SENSUS, the device is a collar placed around the lower leg that electrically stimulates good nerves in order to reduce pain signals from damaged nerves.

The company said that the clearance will enable it to launch the system in the fourth quarter of 2012.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1